Literature DB >> 25682742

MicroRNA-182 inhibits proliferation through targeting oncogenic ANUBL1 in gastric cancer.

Lin Tang1, Feng Chen2, Er-Jun Pang2, Zhi-Qi Zhang2, Bing-Wei Jin2, Wei-Feng Dong2.   

Abstract

MicroRNA-182 (miR-182) is significantly downregulated in human gastric tissue samples. Overexpression of miR-182 suppresses the proliferation and colony formation of gastric cancer cells. However, new aspects of the mechanism are still emerging in gastric cancer. ANUBL1, also known as ZFAND4 (zinc finger, AN1-type domain 4), its roles are scarely reported in cancer. In this study, we not only showed that ANUBL1 as an oncogene was upregulated and could promote proliferation of SGC-7901 cells, but also demonstrated that its over-expression led to a strong decrease of miR-182 expression and expression of ANUBL1 was in turn directly downregulated by miR-182, thereby establishing a negative feedback loop between miR-182 and ANUBL1. The elucidation of the mechanisms of miR-182 targeting ANUBL1 in gastric cancer helps us to further understand the mechanism of gastric cancer initiation and progression.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25682742     DOI: 10.3892/or.2015.3798

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  16 in total

Review 1.  Understanding the CREB1-miRNA feedback loop in human malignancies.

Authors:  Ya-Wen Wang; Xu Chen; Rong Ma; Peng Gao
Journal:  Tumour Biol       Date:  2016-04-09

2.  Tissue microRNA-182 expression level and its potential prognostic value for papillary thyroid carcinoma.

Authors:  Xing-Guo Yao; Qiang Tan; Ping-Ping Liu; Ling-Jun Feng
Journal:  Int J Clin Exp Pathol       Date:  2019-08-01

3.  Expression of NUAK2 in gastric cancer tissue and its effects on the proliferation of gastric cancer cells.

Authors:  Lin Tang; Shu-Juan Tong; Zhen Zhan; Qian Wang; Yuan Tian; Feng Chen
Journal:  Exp Ther Med       Date:  2016-12-19       Impact factor: 2.447

4.  MiRNA-10a is upregulated in NSCLC and may promote cancer by targeting PTEN.

Authors:  Tao Yu; Lei Liu; Jing Li; Mingxia Yan; Hechun Lin; Ying Liu; Dandan Chu; Hong Tu; Aiqin Gu; Ming Yao
Journal:  Oncotarget       Date:  2015-10-06

Review 5.  Dysregulation and functional roles of miR-183-96-182 cluster in cancer cell proliferation, invasion and metastasis.

Authors:  Yi Ma; A-Juan Liang; Yu-Ping Fan; Yi-Ran Huang; Xiao-Ming Zhao; Yun Sun; Xiang-Feng Chen
Journal:  Oncotarget       Date:  2016-07-05

6.  MicroRNA-7 functions as a tumor-suppressor gene by regulating ILF2 in pancreatic carcinoma.

Authors:  Yiliang Bi; Wei Shen; Min Min; Yan Liu
Journal:  Int J Mol Med       Date:  2017-02-17       Impact factor: 4.101

7.  MicroRNA-182 prevents vascular smooth muscle cell dedifferentiation via FGF9/PDGFRβ signaling.

Authors:  Nana Dong; Wei Wang; Jinwei Tian; Zulong Xie; Bo Lv; Jiannan Dai; Rui Jiang; Dan Huang; Shaohong Fang; Jiangtian Tian; Hulun Li; Bo Yu
Journal:  Int J Mol Med       Date:  2017-02-22       Impact factor: 4.101

8.  Down-Regulation of circNRIP1 Promotes the Apoptosis and Inhibits the Migration and Invasion of Gastric Cancer Cells by miR-182/ROCK1 Axis.

Authors:  Lu Liang; Lu Li
Journal:  Onco Targets Ther       Date:  2020-06-30       Impact factor: 4.147

9.  miR-590-5p regulates gastric cancer cell growth and chemosensitivity through RECK and the AKT/ERK pathway.

Authors:  Bo Shen; Shaorong Yu; Yan Zhang; Yuan Yuan; Xiaoyou Li; Jian Zhong; Jifeng Feng
Journal:  Onco Targets Ther       Date:  2016-10-03       Impact factor: 4.147

10.  miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8.

Authors:  Yao Liu; Bing Zhang; Tiefeng Shi; Huadong Qin
Journal:  Onco Targets Ther       Date:  2017-02-24       Impact factor: 4.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.